文献引用
-
1) Nesfatin-1 alleviates hyperoxia-induced lung injury in newborn mice by inhibiting oxidative stress through regulating SIRT1/PGC-1α pathway.
-
2) Edaravone Dexborneol Alleviates Neuroinflammation by Reducing Neuroglial Cell Proliferation and Suppresses Neuronal Apoptosis/Autophagy in Vascular Dementia Rats.
-
3) PAG neuronal NMDARs activation mediated morphine-induced hyperalgesia by HMGB1-TLR4 dependent microglial inflammation.
-
4) NLRP3 in the GABAergic neuron induces cognitive impairments in a mouse model of hemorrhage shock and resuscitation.
-
5) Adiponectin Promotes Neurogenesis After Transient Cerebral Ischemia Through STAT3 Mediated BDNF Upregulation in Astrocytes.
-
6) The increased expression of cytokeratin 13 leads to an increase in radiosensitivity of nasopharyngeal carcinoma HNE-3 cells by upregulating ERRFI1.
-
7) Rosmarinic acid alleviates intestinal inflammatory damage and inhibits endoplasmic reticulum stress and smooth muscle contraction abnormalities in intestinal tissues by regulating gut microbiota.
-
8) CD40LG and GZMB were correlated with adipose tissue macrophage infiltration and involved in obstructive sleep apnea related metabolic dysregulation: Evidence from bioinformatics analysis.
-
9) Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.
-
10) IL1RAP Knockdown in LPS-Stimulated Normal Human Astrocytes Suppresses LPS-Induced Reactive Astrogliosis and Promotes Neuronal Cell Proliferation.
-
11) Identification and validation of novel biomarkers associated with immune infiltration for the diagnosis of osteosarcoma based on machine learning.
-
12) Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma.
-
13) 25-HC promotes hepatocellular carcinoma metastasis through up-regulation of TLR4 dependent FABP4.
-
14) LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance.
-
15) CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer.